表紙
市場調查報告書
商品編碼
1084473

Scopolamine的全球市場:規模,佔有率,趨勢,預測(2022年∼2028年)

Scopolamine Market - Size, Share, Trends, and Forecast, 2022 - 2028

出版日期: | 出版商: Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球Scopolamine的市場規模,由於長時間久坐的工作生活方式的人口增加,大腸激躁症等腸胃障礙等所促進。

本報告提供全球Scopolamine市場調查,市場概要,市場規模和預測,趨勢,成長要素,阻礙因素,各劑型、流通管道、地區的分析,及競爭情形等資訊。

目錄

第1章 調查目的、前提條件

  • 調查目的
  • 假設
  • 簡稱

第2章 市場概要

  • 報告的說明
    • 市場定義和範圍
  • 摘要整理
    • 市場明細:各劑型
    • 市場明細:各流通管道
    • 市場明細:各地區
  • Coherent Opportunity Map(COM)

第3章 市場動態,法規,及趨勢分析

  • 市場動態
    • 促進因素
    • 阻礙因素
    • 市場機會
  • 影響分析
  • 市場趨勢
  • 主要的發展
  • 流行病學
  • 成果概要
  • 醫藥品的收益的可能性
  • 波特的五力分析
  • PEST分析

第4章 全球Scopolamine市場:各劑型(2017年∼2028年)

  • 簡介
  • 平板電腦
  • 糖漿
  • 注射
  • 貼片(修補程式)
  • 其他

第5章 全球Scopolamine市場:各流通管道(2017年∼2028年)

  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第6章 全球Scopolamine市場:各地區(2017年∼2028年)

  • 簡介
  • 北美
  • 歐洲
  • 亞太地區
  • 南美
  • 非洲
  • 中東

第7章 競爭情形

  • 熱圖分析
  • 企業簡介
    • Baxter International Inc.
    • Dosage Form Portfolio
    • GlaxoSmithKline plc
    • Dosage Form Portfolio
    • Novartis AG
    • Dosage Form Portfolio
    • Perrigo Company plc.
    • Dosage Form Portfolio
    • Caleb Pharmaceuticals, Inc.
    • Dosage Form Portfolio
    • Myungmoon Pharma Co. LTD.
    • Dosage Form Portfolio
    • Alchem International
    • Dosage Form Portfolio
    • Phytex Australia
    • Dosage Form Portfolio
    • Centroflora-Cms
    • Dosage Form Portfolio
    • Alkaloids of Australia
    • Dosage Form Portfolio
    • Fine Chemicals Corporation
    • Dosage Form Portfolio
  • 分析師的見解

第8章 Section

目錄
Product Code: CMI1965

Scopolamine is an oral, intravenous, ophthalmic or topical drug derived from plants of the nightshade family (Solanaceae), specifically Hyoscyamus Niger and Atropa belladonna, with anticholinergic, antiemetic and antivertigo properties.

It has applications in prevention of nausea, vomiting, and dizziness associated with motion sickness and recovery from anesthesia and surgery. Scopolamine may also be used to treat certain stomach or intestinal problems, such as spastic muscle states, diverticulitis, irritable bowel syndrome, Parkinson-like conditions etc.

Market Dynamics

Changing lifestyle that involves minimal or absolutely no physical work in a routine life are responsible for the malfunctioning of the digestive as well as gastrointestinal system. Increasing number of population adopting long-hour sedentary work lifestyle are likely to be affected with gastrointestinal disorders such as irritable bowel syndrome and thus are responsible to support growth of the global scopolamine market.

However, various side-effects observed while using these drugs such as retarded motion, drowsiness, and diluted pupils, may limit their growth to some extent in the near future.

Key features of the study:

This report provides in-depth analysis of the scopolamine market, market size (US$ Mn) and cumulative annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year

It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by the leading players

It profiles leading players in the global scopolamine market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies

Key players covered as a part of this study include Baxter International Inc., GlaxoSmithKline plc, Novartis AG, Perrigo Company plc, Caleb Pharmaceuticals, Inc., Myungmoon Pharma Co. LTD., Alchem International, Phytex Australia, Centroflora-Cms, Alkaloids of Australia, and Fine Chemicals Corporation.

Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics

The global scopolamine market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for scopolamine market, research and consulting firms, new entrants, and financial analysts

Detailed Segmentation:

Global Scopolamine Market, By Dosage Form:

Tablet

Syrup

Injection

Patch

Others

Global Scopolamine Market, By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Global Scopolamine Market, By Region:

North America

By Country:

U.S.

Canada

By Dosage Form:

Tablet

Syrup

Injection

Patch

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Europe

By Country:

U.K.

Germany

Italy

Spain

France

Russia

Rest of Europe

By Dosage Form:

Tablet

Syrup

Injection

Patch

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Asia Pacific

By Country:

Australia

India

China

Japan

ASEAN

South Korea

Rest of Asia Pacific

By Dosage Form:

Tablet

Syrup

Injection

Patch

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Latin America

By Country:

Brazil

Mexico

Argentina

Rest of Latin America

By Dosage Form:

Tablet

Syrup

Injection

Patch

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Middle East

By Country:

GCC

Israel

Rest of Middle East

By Dosage Form:

Tablet

Syrup

Injection

Patch

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Africa

By Country:

South Africa

Central Africa

North Africa

By Dosage Form:

Tablet

Syrup

Injection

Patch

Others

By Distribution Channel:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Company Profiles

Baxter International Inc.*

Company Overview

Product Portfolio

Financial Performance

Recent Highlights

Strategies

GlaxoSmithKline plc

Novartis AG

Perrigo Company plc.

Caleb Pharmaceuticals, Inc.

Myungmoon Pharma Co. LTD.

Alchem International

Phytex Australia

Centroflora-Cms

Alkaloids of Australia

Fine Chemicals Corporation

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Overview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Dosage Form
    • Market Snippet, By Distribution Channel
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Epidemiology
  • Historical Overview
  • Revenue Potential of Drugs
  • PORTER'S Five Forces
  • PEST Analysis

4. Global Scopolamine Market, By Dosage Form, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Tablet
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Syrup
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Patch
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

5. Global Scopolamine Market, By Distribution Channel, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, 2017 - 2028
    • Segment Trends
  • Hospital Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Million)

6. Global Scopolamine Market, By Regions, 2017 - 2028, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2028 (%)
    • Y-o-Y Growth Analysis, By Region, 2017 - 2028
    • Regional Trends
  • North America
    • Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.S.
    • Canada
  • Europe
    • Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • U.K.
    • Germany
    • Italy
    • France
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Latin America
    • Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Africa
    • Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • Northern Africa
    • Central Africa
    • South Africa
  • Middle East
    • Market Size and Forecast, By Dosage Form, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Distribution Channel, 2017 - 2028, (US$ Million)
    • Market Size and Forecast, By Country, 2017 - 2028, (US$ Million)
    • GCC Countries
    • Israel
    • Rest of Middle East

7. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • Baxter International Inc.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • GlaxoSmithKline plc
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Novartis AG
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Perrigo Company plc.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Caleb Pharmaceuticals, Inc.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Myungmoon Pharma Co. LTD.
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Alchem International
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Phytex Australia
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Centroflora-Cms
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Alkaloids of Australia
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
    • Fine Chemicals Corporation
    • Company Overview
    • Dosage Form Portfolio
    • Financial Performance
    • Recent Highlights
    • Strategies
  • Analyst Views

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact